A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Clinical trial NCT04777396 · COMPLETED

Trial details

NCT number: NCT04777396
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Alzheimer's Disease

Start date: 2021-05-18
Primary completion: 2025-09-16
Enrollment: 1840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.